✦ LIBER ✦

Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease

✍ Scribed by Michael Tolentino

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-VEGF Aptamer (Pegaptanib) Therapy f

✍ EUGENE W.M. NG; ANTHONY P. ADAMIS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Ocular Anti-VEGF Therapy for Diabetic Re

✍ Simo, R.; Sundstrom, J. M.; Antonetti, D. A. 📂 Article 📅 2014 🏛 American Diabetes Association 🌐 English ⚖ 880 KB

Ocular and systemic toxicity of intravit

✍ Buitrago, Emiliano; Del Sole, María José; Torbidoni, Ana; Fandino, Adriana; Aspr 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 775 KB

Combined intravitreal anti-VEGF and vert

✍ Han, D P; McAllister, J T; Weinberg, D V; Kim, J E; Wirostko, W J 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 137 KB

Challenges in ocular infectious diseases

✍ Randall J. Olson 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Challenges in ocular infectious diseases

✍ Elif Oguz; Halit Oguz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB